USANA HEALTH SCIENCES INC Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2011 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Usana Health Sciences Inc quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2011 to Q4 2023.
  • Usana Health Sciences Inc Deferred Tax Assets, Valuation Allowance for the quarter ending December 30, 2023 was $137M, a 16.2% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $137M +$19.1M +16.2% Dec 30, 2023 10-K 2024-02-27
Q4 2022 $118M +$18.2M +18.2% Dec 31, 2022 10-K 2024-02-27
Q4 2021 $100M +$18.6M +22.8% Jan 1, 2022 10-K 2023-02-28
Q4 2020 $81.4M +$17.1M +26.6% Jan 2, 2021 10-K 2022-03-01
Q4 2019 $64.3M +$20.1M +45.4% Dec 28, 2019 10-K 2021-03-02
Q4 2018 $44.2M +$30.2M +216% Dec 29, 2018 10-K 2020-02-25
Q4 2017 $14M +$13.3M +2084% Dec 30, 2017 10-K 2019-02-26
Q4 2016 $640K +$33K +5.44% Dec 31, 2016 10-K 2018-02-28
Q4 2015 $607K +$81K +15.4% Jan 2, 2016 10-K 2017-03-01
Q4 2014 $526K -$4K -0.76% Jan 3, 2015 10-K 2016-03-01
Q4 2013 $530K -$1.07M -66.8% Dec 28, 2013 10-K 2015-03-17
Q4 2012 $1.6M -$186K -10.4% Dec 29, 2012 10-K 2014-03-13
Q4 2011 $1.78M Dec 31, 2011 10-K 2013-03-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.